MedPath

Diagnostic performance of SAFE score

Not Applicable
Active, not recruiting
Conditions
Diseases of the digestive system
Registration Number
KCT0008705
Lead Sponsor
Hanyang University Seoul Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Active, not recruiting
Sex
All
Target Recruitment
30000
Inclusion Criteria

Among patients who performed liver fibrosis scan at the Department of Gastroenterology between 2018 and 2021, the SAFE score can be calculated

Exclusion Criteria

1) Fibroscan
2) Insufficient or missing tests to determine SAFE

Study & Design

Study Type
Observational Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
SAFE prediction model, a new evaluation index, describes sensitivity, specificity, and AUROC to predict intrahepatic fibrosis when hepatic fibrosis scan is used as the gold standard
Secondary Outcome Measures
NameTimeMethod
The sensitivity, specificity, and AUROC of the SAFE score were analyzed in subgroups divided into the presence of fatty liver, diabetes, and metabolic syndrome.
© Copyright 2025. All Rights Reserved by MedPath